Discussion  by unknown
JOURNAL OF VASCULAR SURGERY
Volume 57, Number 6 Goodney et al 147929. Healthy People 2020 - Improving the Health of Americans. Available at:
http://www.healthypeople.gov/2020/default.aspx. Accessed January
17, 2013.
30. Bruckner M, Mangan M, Godin S, Pogach L. Project LEAP of New
Jersey: lower extremity amputation prevention in persons with type 2
diabetes. Am J Manag Care 1999;5:609-16.
31. Goldberg J, Cronenwett J, Goodney PP. Effect of race and diabetes on
amputation prevalence. J Vasc Surg 2012;56:1663-8.
32. Van Gils CC, Wheeler LA, Mellstrom M, Brinton EA, Mason S,
Wheeler CG. Amputation prevention by vascular surgery and
podiatry collaboration in high-risk diabetic and nondiabetic patients.
The operation desert foot experience. Diabetes Care 1999;22:
678-83.33. Mills JL Sr, Armstrong DG, Andros G. Rescuing Sisyphus: the team
approach to amputation prevention. J Vasc Surg 2010;52:1-2S.
34. Simons JP, Goodney PP, Nolan BW, Cronenwett JL, Messina LM,
Schanzer A. Failure to achieve clinical improvement despite graft
patency in patients undergoing infrainguinal lower extremity bypass for
critical limb ischemia. J Vasc Surg 2010;51:1419-24.Submitted Oct 9, 2012; accepted Nov 16, 2012.
Additional material for this article may be found online
at www.jvascsurg.org.DISCUSSIONDr John Ricotta (Washington, DC). Some of the critics of
this type of analysis suggest that the regional approach blunts the
impact of local socioeconomic factors and that when you look at
areas within a region, the socioeconomics play a more important
role than the number and type of services within the broad region.
Isn’t it possible that the intensity of vascular care really reﬂects the
socioeconomic status of these various regions? I say this coming
from Washington, DC, where we have a very high incidence of
amputation, and I can assure you that we’ve got lots of vascular
surgeons. Many believe that access to care is the problem. I’m
not sure this is the case. My personal experience is that availability
of services is not the major problem. Rather, people of low socio-
economic status do not access the care that is available until it’s too
late. We see a lot of patients for the ﬁrst time where revasculariza-
tion is not an option.
Dr Philip P. Goodney. I think this reﬂects exactly that point.
And, much of the research, as it falls out of the Dartmouth Atlas,
is: Is too much health care being provided? And, I think our
project here shows that perhaps in this setting, health care is
needed for these patients, and it was needed earlier. These are
patients who have insurance, they have Medicare, and they should
have probably gotten more vascular care than they did in the year
prior to amputation.
So, Dr Ricotta, I think your point is well taken. There is a pop-
ulation of patients in whom vascular care is not aligned with need,
and that’s why I think our study shows not that we need more
vascular surgeons, but that we need to properly direct amputation
prevention initiatives toward those patients who need them the
most. So, I agree entirely with your discussion.
Dr Ronald Dalman (Stanford, Calif). Phil, I really am very
impressed with your continuing insight into these processes. I
want to just provide a cautionary observation about the validity
of some of these observations taken from 30,000” feet.
I noticed with interest that you mentioned that Santa Cruz,
California, for example, does well with amputations versus inten-
sity of vascular care, but there are, in fact, no board-certiﬁed
vascular surgeons practicing in Santa Cruz, and there are a number
of interventional radiologists and others who do a lot of proce-
dures but not amputations. So, when the patients ultimately do
need an amputation, they are referred to other regional “amputa-
tion centers,” with which we have some experience.
So, I would just point out this problem, which is when you
draw these conclusions taken from administrative databases, there
are a lot of other details that might be lost in translation, as far as
that goes.
Dr Goodney. That’s a great question, Dr Dalman. I appre-
ciate you bringing it up. All these analyses are based on a patient’s
zip code of residence, so it’s where they live, not necessarily where
they received their treatment. So, for exactly that point, one wants
to make sure the regions aren’t punished for providing high-risk
care. So, if your hospital is the referral center for the most complex
patients, this analysis wouldn’t necessarily penalize you. But, that’s
certainly a good point.In addition, our data is 30,000” data. However, the persistent
trend is that no matter how we looked at it, we found the same
effect and therefore we think it likely represents a real ﬁnding.
Dr John Hallett (Charleston, SC). Phil, I speak on behalf of
the Carolinas Vascular Study Group, because you’ve really focused
in our region.
I think there is an opportunity for the vascular study groups to
improve these results. In South Carolina, we were once 50th in the
country in terms of stroke because of hypertension. And, Dr Brent
Egan at the Medical University has led a statewide program that
improved hypertension therapy and reduced stroke over the last
25 years.
So, with this kind of information, we need to go back to our
regions where this is a problem and think about how we increase
access and education to decrease amputations.
Thank you very much for bringing this forward.
Dr Goodney.Well, thanks, Dr Hallett, and I appreciate it. As
the VQI gains momentum, I think that’s a perfect forum to
address this issue. I was pleased to see how these results from
our reﬂected changes that could potentially be made at a national
practice. And, I agree that the VQI could potentially serve as an
outstanding forum to push those changes ahead.
Dr Amy Reed (Hershey, Pa). I have two questions. Infection
often plays a role. How many of these patients had amputations for
infection, because clearly some of them don’t need the revascular-
ization procedures performed.
And also, with the advent of a lot of telemedicine, some of
that more in the VA, does your working group have any ideas of
how you might go forward or how we could take this out into
some of the underserved areas to use perhaps telemedicine? Are
there any other areas where telemedicine is being used and we
might be able to piggyback on that?
Dr Goodney. At the inception of this project, I wondered
that very question, and should the intensity of care ever be
100%, should all these patients get revascularization? The answer
is, of course, no, as certainly there is going to be the patient
with diabetes and palpable pulses who lost their foot because of
advanced local disease.
I don’t know exactly what that rate should be. I suspect it’s
somewhere in between 33% and 60%. The exact proportion of
amputations that had only infectious codes as compared to any
other of the PAD codes I would estimate at approximately 20%.
And, as for your second question, I think the VA will be where
we want to turn some of our efforts in the future because in
essence it obviates many of the access-to-care issues we’ve encoun-
tered here. There are vans that will bring you to the VA. There is
podiatric care integrated into vascular care there. So in some sense,
it might actually sort of simulate what we might aim towards in the
future. And, telemedicine will certainly play a big part in that.
Dr Eugene Lee (Sacramento, Calif). Is there a biologic effect
that may cause African-Americans to have higher amputation rates
or is race a surrogate for lower socioeconomic levels which may be
the actual cause for the higher amputation rates?
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similar amputation rates to their non-black counterparts, so at least
from the 30,000” level, I’d say maybe not. I’m certainly not a basic
scientist and that would be a presumption on my part to say that.
But, at least our data do not suggest that there are inherent differ-
ences. They seem to be reﬂected in patterns of practice.
Dr Hernan Bazan (New Orleans, La). Very nice presentation.
Were you able to look at age differences? The reason why I ask that
is because if you look at a map of stroke in the U.S. (the “stroke
belt”), it almost overlaps the map that you showed. There isa hypothesis that atherosclerotic disease is advanced in the
Southeast United States because of diet (high saturated fats),
smoking, and even cultural things that people do. So, I wonder
if you noted any differences in age and presentation in the South-
east or the areas where there are higher amputations than in other
areas?
Dr Goodney. We did see a strong effect by age, a more than
2.5-times effect in terms of the risk of undergoing amputation
without an antecedent revascularization, and those effects were
indeed stronger in the amputation belt.
